Categories
Tags
Abbott Advertising AstraZeneca Barack Obama Biotechnology and Pharmaceuticals Breast cancer Bristol Myers Squibb business Cancer Clinical trial Conditions and Diseases Deal Eli Lilly European Commission European Union FDA Food and Drug Administration Genentech generics GlaxoSmithKline Google GSK HBA Health Health care Johnson & Johnson layoffs Lilly Margaret Hamburg Marketing Merck Novartis Pfizer Pharma Pharmaceutical drug pharmaceutical industry Research and development Roche Sanofi-Aventis Schering Plough social media Twitter U.S. Food and Drug Administration United States Wyeth
Technology News
BioPharm News- Shire Gains European Approval for its Gaucher Disease Treatment
- Mtech Bioprocess Scale-Up Facility to Double in Staff and Size
- ImClone Closes Plant in New Jersey, Consolidating Erbitux Manufacture
- EMA and FDA Seek Applicants for Joint GMP Inspections
- ATMI Expands Bloomington, Minnesota Manufacturing Facility
Clinical Trials News- CRF Health Achieves EXACT ePRO Vendor Certification for Windows Mobile Systems
- ACR Image Metrix Establishes Global Presence
- BioPharm Systems Named to the 2010 Inc. 500|5000 List of Fastest-Growing Companies in the U.S.
- CRF Health Doubles North American Headquarters
- Oracle Completes Acquisition of Phase Forward
Blogroll
-
Meta
Tag Archives: Prescription drug
Unbranded Pharma Sites Gain Traction
Image by alles-schlumpf via Flickr
The popularity of unbranded pharma Web sites amongst consumers appears to be on an up tick, according to new data released by Manhattan Research this week.
The report, “Unbranded Web sites: Brand Reach throughout the Patient Life Cycle” looked at how many consumers actively use unbranded pharma sites and to what degree [...]
Posted in Marketing Also tagged Conditions and Diseases, Data, Health, Manhattan Research, Monique Levy, WebMD, World Wide Web Leave a comment
Pharma Cheers Health Reform Legislation
Image by SEIU International via Flickr
After months of increasingly rancorous debate, the House finally approved legislation March 21 that makes significant changes in the nation’s health care system. The Senate is slated to approve the House-passed changes to its original reform bill shortly.
Of most importance to pharmaceutical companies, the legislation promises to significantly expand the [...]
Posted in News Also tagged Health care, health insurance, Insurance, Medicaid, Medicare, Medicare Part D coverage gap, United States 3 Comments
FDA Panel Calls for Ban on Narcotic/Tylenol Combo Drugs
Image via Wikipedia
A joint committee of three FDA advisory groups voted on Tuesday to recommend the elimination of prescription combination drugs containing acetaminophen due to a spike in instances of liver-induced toxicity.
The panel of experts, physicians, and regulators voted 20 to 17 in favor of banning acetaminophen combo drugs such as Vicodin and Percocet. They [...]
Posted in Regulatory, Safety Also tagged acetaminophen, Center for Drug Evaluation and Research, Drug overdose, FDA, Health, liver toxicity, overdose, Paracetamol, percocet, U.S. Food and Drug Administration, Vicodin 1 Comment

Mass Gift Ban Repeal Efforts Fizzle